The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes-Reference-Cited by-同舟云学术

The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes

Published:2011-01 Issue:1 Volume:46 Page:71-76
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Deng Jifeng,Peng Li,Zhang Guicheng,Lan Xiaobing,Li Chufang,Chen Fuxin,Zhou Yayao,Lin Zuoxian,Chen Ling,Dai Renke,Xu Hongjiang,Yang Ling,Zhang Xiquan,Hu Wenhui

Funder

Bureau of Science and Technology of Guangzhou Municipality, China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference29 articles.

1. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections

2. Fact Sheet No. 138,2002

3. Chapter 19. Glucagon and Glucagon-Like Peptide-1

4. Glucagon-like peptide-1: A basis for new approaches to the management of diabetes

5. Chapter 19. DPP-IV inhibition and therapeutic potential

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the selective and nanomolar inhibitor of DPP-4 more potent than sitagliptin by structure-guided rational design;European Journal of Medicinal Chemistry;2024-12

2. Computational approaches for lead compound discovery in dipeptidyl peptidase-4 inhibition using machine learning and molecular dynamics techniques;Computational Biology and Chemistry;2024-10

3. 3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line;Frontiers in Chemistry;2024-05-23

4. Synthesis and anti-microbial studies of new series of 1,2,3,4-tetrazole integrated thieno[2,3-d]pyrimidine derivatives;Journal of Molecular Structure;2024-01

5. New Hybrid Cytisine Derivatives Containing a Thienopyrimidine Fragment;Chemistry of Natural Compounds;2024-01